AeroVironment Appoints William Lynn III to Board of Directors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
AeroVironment (AVAV) announced the appointment of William Lynn III to its Board of Directors, effective June 24. Lynn served as Chairman and CEO of Leonardo DRS (DRS) from 2012 until 2026.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVAV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVAV
Wall Street analysts forecast AVAV stock price to rise
13 Analyst Rating
13 Buy
0 Hold
0 Sell
Strong Buy
Current: 139.000
Low
315.00
Averages
390.75
High
450.00
Current: 139.000
Low
315.00
Averages
390.75
High
450.00
About AVAV
AeroVironment, Inc. is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. The Company develops and deploys autonomous systems, uncrewed aircraft systems (UAS), precision strike systems, counter-UAS (C-UAS) technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Its segments include Autonomous Systems (AxS) and Space, Cyber, and Directed Energy (SCDE). The AxS segment focuses on the design, development, production, delivery, and support of intelligent, multi-domain robotic systems, including UAS, uncrewed underwater vehicles and ground robot systems. It primarily serves organizations within or supplying the U.S. Department of Defense (DoD), other federal agencies, and international allied governments. The SCDE segment focuses on advanced technologies in the space domain providing space-based and ground-based platforms, cyber capabilities, and directed energy systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AeroVironment Reports Strong Q4 Earnings Exceeding Expectations
- Earnings Beat: AeroVironment reported Q4 earnings of $1.84 per share, surpassing analyst expectations of $1.46, indicating a significant improvement in profitability that is likely to drive stock price higher.
- Significant Revenue Growth: The company achieved total revenue of $642 million, more than doubling the analyst estimate of $559 million, demonstrating strong demand in the drone market and an expansion of market share.
- Growing Funded Backlog: AeroVironment's funded backlog reached $1.2 billion, up 65% year-over-year, although only slightly above the $1.1 billion from the previous quarter, reflecting stability in future orders.
- Strong Performance in Autonomous Systems: Revenue from autonomous systems was $492 million, significantly exceeding the market expectation of $402 million, showcasing the company's competitive edge and robust demand in this sector.
See More
Semiconductor Stocks Surge; Watts Water Upgraded
- Semiconductor ETF Performance: The VanEck Semiconductor ETF (SMH) is on track for a 70% surge in Q2, driving chip stocks higher, with Astera Labs up 7%, KLA Corp up 8%, and Applied Materials up 5%, indicating strong market confidence in the semiconductor sector.
- Watts Water Upgrade: Watts Water Technologies jumped over 7% after Barclays upgraded its rating to overweight, as the company is seen as best positioned to benefit from the data center capital expenditures cycle with its expanding portfolio in waste and water technology.
- Abivax Stock Surge: U.S.-traded shares of French biotech company Abivax soared 40% after releasing new data on its ulcerative colitis treatment, showing malignancy rates in line with expectations and over 37% of initially non-responsive patients achieving clinical remission after about 10 months, highlighting treatment efficacy.
- Air Products Project Cancellation: Air Products and Chemicals rose over 8% after announcing it would not proceed with its Louisiana Clean Energy Complex, which is expected to incur up to $2.9 billion in pretax charges, reflecting the company's stringent financial return criteria.
See More
US Stocks Rally as Tech Leads Gains Amid Strong Economic Signals
- Tech Stocks Lead Market: The S&P 500 rose by 0.34% and the Nasdaq 100 by 0.97%, reflecting investor optimism ahead of a strong earnings season, particularly driven by an investment boom in artificial intelligence.
- Strong Labor Market: May JOLTS job openings unexpectedly increased by 9,000 to a two-year high of 7.594 million, indicating a stronger labor market than anticipated, which may influence the Fed's monetary policy direction.
- Positive Global Economic Signals: China's June manufacturing PMI rose to 50.3, exceeding expectations, indicating signs of economic recovery that support global growth prospects and further bolster market confidence.
- Optimistic Earnings Outlook: Bloomberg Intelligence forecasts a 23% increase in Q2 earnings, close to Q1's 30% growth, primarily driven by AI infrastructure stocks expected to contribute nearly 60% of S&P 500 earnings growth.
See More
Tech Stocks Rise on Tuesday Afternoon
- Tech Stock Recovery: On Tuesday afternoon, tech stocks broadly rose, reflecting a gradual recovery in market confidence towards the tech sector, likely driven by optimistic investor expectations regarding future growth potential.
- Strong ETF Performance: The rise of the State Street Technology Select Sector SPDR ETF indicates sustained investor interest in the tech sector, which may attract more capital inflows into this area, further boosting related stock prices.
- Improved Market Sentiment: The increase in tech stocks may be linked to an overall improvement in market sentiment, as investors reassess the long-term value of tech companies following recent volatility, especially in the context of accelerated innovation and digital transformation.
- Enhanced Investor Confidence: With the recovery of tech stocks, investor confidence is likely to strengthen, potentially leading to increased capital inflows into the tech industry, further driving the sector's recovery and growth.
See More
Multiple Companies Face Class Action Lawsuits
- AeroVironment Lawsuit: AeroVironment is accused of failing to disclose competitive risks related to the SCAR program during the period from June 2025 to March 2026, which may mislead investors about the company's prospects and negatively impact its stock price and market confidence.
- Calix Lawsuit: Calix's first-quarter margins were significantly influenced by advanced purchasing of memory components, yet the company did not inform investors about its dwindling supply, leading to negative margin pressure that could affect future financial performance.
- Zoetis Lawsuit: Zoetis failed to disclose a decline in veterinarian prescription growth and market share loss due to FDA safety warnings from January 2025 to May 2026, potentially undermining investor confidence in its market position.
- Lucid Lawsuit: Lucid faced delivery disruptions due to supplier quality issues in early 2026 and did not accurately reflect its manufacturing capabilities, which may lead to investor misunderstandings about its operational strength and affect stock performance.
See More
Multiple Companies Facing Class Action Lawsuits
- Calix, Inc. Lawsuit: During the class period from January 28 to April 21, 2026, Calix is accused of failing to disclose that its first-quarter margins benefited from advanced purchasing of memory components, misleading investors about the company's prospects, potentially impacting stock prices.
- AeroVironment, Inc. Allegations: From June 25, 2025, to March 10, 2026, AeroVironment is alleged to have underestimated imminent competition from other vendors, leading to a significant overstatement of its business prospects, which could negatively affect investor confidence.
- Zoetis Inc. Lawsuit: Between January 14 and May 6, 2026, Zoetis is accused of failing to disclose a sharp decline in veterinarian prescription growth and market share losses, which may lead to decreased investor confidence in the company's future.
- Lucid Group, Inc. Allegations: From February 25 to April 13, 2026, Lucid faced significant delivery disruptions due to supplier quality issues, failing to accurately disclose enhancements to its manufacturing capabilities, which could materially impact its financial results.
See More
AeroVironment Reports Strong Q4 Earnings Exceeding Expectations
- Earnings Beat: AeroVironment reported Q4 earnings of $1.84 per share, surpassing analyst expectations of $1.46, indicating a significant improvement in profitability that is likely to drive stock price higher.
- Significant Revenue Growth: The company achieved total revenue of $642 million, more than doubling the analyst estimate of $559 million, demonstrating strong demand in the drone market and an expansion of market share.
- Growing Funded Backlog: AeroVironment's funded backlog reached $1.2 billion, up 65% year-over-year, although only slightly above the $1.1 billion from the previous quarter, reflecting stability in future orders.
- Strong Performance in Autonomous Systems: Revenue from autonomous systems was $492 million, significantly exceeding the market expectation of $402 million, showcasing the company's competitive edge and robust demand in this sector.
See More
Semiconductor Stocks Surge; Watts Water Upgraded
- Semiconductor ETF Performance: The VanEck Semiconductor ETF (SMH) is on track for a 70% surge in Q2, driving chip stocks higher, with Astera Labs up 7%, KLA Corp up 8%, and Applied Materials up 5%, indicating strong market confidence in the semiconductor sector.
- Watts Water Upgrade: Watts Water Technologies jumped over 7% after Barclays upgraded its rating to overweight, as the company is seen as best positioned to benefit from the data center capital expenditures cycle with its expanding portfolio in waste and water technology.
- Abivax Stock Surge: U.S.-traded shares of French biotech company Abivax soared 40% after releasing new data on its ulcerative colitis treatment, showing malignancy rates in line with expectations and over 37% of initially non-responsive patients achieving clinical remission after about 10 months, highlighting treatment efficacy.
- Air Products Project Cancellation: Air Products and Chemicals rose over 8% after announcing it would not proceed with its Louisiana Clean Energy Complex, which is expected to incur up to $2.9 billion in pretax charges, reflecting the company's stringent financial return criteria.
See More
US Stocks Rally as Tech Leads Gains Amid Strong Economic Signals
- Tech Stocks Lead Market: The S&P 500 rose by 0.34% and the Nasdaq 100 by 0.97%, reflecting investor optimism ahead of a strong earnings season, particularly driven by an investment boom in artificial intelligence.
- Strong Labor Market: May JOLTS job openings unexpectedly increased by 9,000 to a two-year high of 7.594 million, indicating a stronger labor market than anticipated, which may influence the Fed's monetary policy direction.
- Positive Global Economic Signals: China's June manufacturing PMI rose to 50.3, exceeding expectations, indicating signs of economic recovery that support global growth prospects and further bolster market confidence.
- Optimistic Earnings Outlook: Bloomberg Intelligence forecasts a 23% increase in Q2 earnings, close to Q1's 30% growth, primarily driven by AI infrastructure stocks expected to contribute nearly 60% of S&P 500 earnings growth.
See More
Tech Stocks Rise on Tuesday Afternoon
- Tech Stock Recovery: On Tuesday afternoon, tech stocks broadly rose, reflecting a gradual recovery in market confidence towards the tech sector, likely driven by optimistic investor expectations regarding future growth potential.
- Strong ETF Performance: The rise of the State Street Technology Select Sector SPDR ETF indicates sustained investor interest in the tech sector, which may attract more capital inflows into this area, further boosting related stock prices.
- Improved Market Sentiment: The increase in tech stocks may be linked to an overall improvement in market sentiment, as investors reassess the long-term value of tech companies following recent volatility, especially in the context of accelerated innovation and digital transformation.
- Enhanced Investor Confidence: With the recovery of tech stocks, investor confidence is likely to strengthen, potentially leading to increased capital inflows into the tech industry, further driving the sector's recovery and growth.
See More
Multiple Companies Face Class Action Lawsuits
- AeroVironment Lawsuit: AeroVironment is accused of failing to disclose competitive risks related to the SCAR program during the period from June 2025 to March 2026, which may mislead investors about the company's prospects and negatively impact its stock price and market confidence.
- Calix Lawsuit: Calix's first-quarter margins were significantly influenced by advanced purchasing of memory components, yet the company did not inform investors about its dwindling supply, leading to negative margin pressure that could affect future financial performance.
- Zoetis Lawsuit: Zoetis failed to disclose a decline in veterinarian prescription growth and market share loss due to FDA safety warnings from January 2025 to May 2026, potentially undermining investor confidence in its market position.
- Lucid Lawsuit: Lucid faced delivery disruptions due to supplier quality issues in early 2026 and did not accurately reflect its manufacturing capabilities, which may lead to investor misunderstandings about its operational strength and affect stock performance.
See More
Multiple Companies Facing Class Action Lawsuits
- Calix, Inc. Lawsuit: During the class period from January 28 to April 21, 2026, Calix is accused of failing to disclose that its first-quarter margins benefited from advanced purchasing of memory components, misleading investors about the company's prospects, potentially impacting stock prices.
- AeroVironment, Inc. Allegations: From June 25, 2025, to March 10, 2026, AeroVironment is alleged to have underestimated imminent competition from other vendors, leading to a significant overstatement of its business prospects, which could negatively affect investor confidence.
- Zoetis Inc. Lawsuit: Between January 14 and May 6, 2026, Zoetis is accused of failing to disclose a sharp decline in veterinarian prescription growth and market share losses, which may lead to decreased investor confidence in the company's future.
- Lucid Group, Inc. Allegations: From February 25 to April 13, 2026, Lucid faced significant delivery disruptions due to supplier quality issues, failing to accurately disclose enhancements to its manufacturing capabilities, which could materially impact its financial results.
See More
